Slow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn's disease.

A double-blind, placebo-controlled trial of a slow-release preparation of 5-amino-salicylic acid (Pentasa) has been performed in 40 patients with active Crohn's disease. Over a 6-week period, Pentasa (1.5 g daily) was no different to the dummy tablet in terms of clinical activity (Harvey-Bradsh...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Mahida, Y, Jewell, D
Aineistotyyppi: Journal article
Kieli:English
Julkaistu: 1990

Samankaltaisia teoksia